Fat emulsion for artificially feeding seriously ill intensive care patients

A technology of fat emulsion and fatty acid residues, applied in fat emulsion, prevention and treatment of critically ill polyneuropathy) and critically ill myopathy) pharmaceutical preparations, fat emulsion in artificial feeding of sepsis intensive care patients The application field can solve the problems such as unknown secondary complications

Inactive Publication Date: 2011-10-12
B BRAUN MEDICAL
View PDF8 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In addition, little is known about effective nutritional approaches to treat sepsis and secondary complications of intensive care treatment, such as CIP and / or CIM

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Fat emulsion for artificially feeding seriously ill intensive care patients
  • Fat emulsion for artificially feeding seriously ill intensive care patients
  • Fat emulsion for artificially feeding seriously ill intensive care patients

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0054]

[0055] 1) For the fraction of medium-chain triglycerides (caprylic / capric triglycerides), a commercially available mixture was used (Miglyol 812, Sasol Germany GmbH, Witten, Germany).

[0056] 2) As structured lipids, glycerol enptylated in the sn-1 and sn-3 positions of triglycerides and eicosapentaenoic acid (EPA; C20:5 Ω -3) Composition of triglycerides (A).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
Login to view more

Abstract

The present invention relates to a pharmaceutical preparation for the prophylaxis and treatment of critical illness polyneuropathy (CIP) and critical illness myopathy (CIM). The invention further relates to an isotonic fat emulsion comprising at least one triglyceride that comprises at least one fatty acid group having an odd number of carbon atoms, wherein the fatty acid group comprises a carbon chain having 5 to 15 carbon atoms.

Description

technical field [0001] The present invention relates to pharmaceutical preparations for the prevention and treatment of critical illness polyneuropathy (CIP) and critical illness myopathy (CIM). Furthermore, the present invention relates to an isotonic fat emulsion comprising at least one triglyceride comprising at least one fatty acid residue having an odd number of carbon atoms, wherein said fatty acid residue comprises carbon chain. Furthermore, the invention relates to the use of said isotonic fat emulsion as a dietary product, and the invention also relates to the use of said pharmaceutical preparation / isotonic fat emulsion in the context of parenteral nutrition or as a component of a dietary product, in particular the fat emulsion in Application of artificial feeding in intensive care patients with sepsis. Background technique [0002] The survival time of extremely ill intensive care patients can be significantly prolonged due to developments in intensive care medic...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/23A23L1/30A61P3/02
CPCA61K31/225A23L33/12A61K9/0029A61K9/107A61K9/1075A61K31/22A61K31/23A23V2002/00A61P21/00A61P25/00A61P25/02A61P3/02A61P31/04A61P43/00A61K2300/00A61K31/20
Inventor 迈克尔·博尔
Owner B BRAUN MEDICAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap